Babak Javid, MB BChir, PhD

Babak Javid, MB BChir, PhD, is Associate Professor in the Division of Experimental Medicine, University of California, San Francisco. Dr. Javid trained in medicine at the University of Cambridge, completed residency in general (internal) medicine in London and returned to Cambridge as a Medical Research Council (MRC) Clinical Training Fellow for graduate studies under Paul Lehner, investigating cross-presentation by human dendritic cells to cytotoxic T lymphocytes. Following specialist training in infectious diseases, he went to Harvard as an MRC Clinician Scientist Fellow to train with Eric Rubin in mycobacterial genetics, where he first became interested in ‘unique’ aspects of the mycobacterial translation apparatus. From 2011 to 2020 he was Principal Investigator at the Tsinghua University School of Medicine, Beijing, China.

Dr. Javid’s group focuses on tuberculosis pathophysiology from the perspective of both the pathogen and host immunity, and are interested in the role of translational errors in adaptation by Mycobacterium tuberculosis and the role and function of humoral immunity to tuberculosis. Dr. Javid served as Co-Chair of the B cell / Antibody group of the Collaboration for TB Vaccine Discovery from 2018-2023 and serves on the WHO working group for a tuberculosis vaccine roadmap. He is currently an Investigator of the Wellcome Trust and was elected to the ASCI in 2023.